Graduate School of Pharmaceutical Sciences, Osaka University, 1-6, Yamada-oka, Suita, Osaka, 565-0871, Japan.
Department of Formulation Design and Pharmaceutical Technology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
Angew Chem Int Ed Engl. 2023 Nov 27;62(48):e202311058. doi: 10.1002/anie.202311058. Epub 2023 Sep 27.
The pharmacokinetics of pharmaceutical drugs can be improved by replacing C-H bonds with the more stable C-D bonds at the α-position to heteroatoms, which is a typical metabolic site for cytochrome P450 enzymes. However, the application of deuterated synthons is limited. Herein, we established a novel concept for preparing deuterated reagents for the successful synthesis of complex drug skeletons with deuterium atoms at the α-position to heteroatoms. (d -Alkyl)diphenylsulfonium salts prepared from the corresponding nondeuterated forms using inexpensive and abundant D O as the deuterium source with a base, were used as electrophilic alkylating reagents. Additionally, these deuterated sulfonium salts were efficiently transformed into d -alkyl halides and a d -alkyl azide as coupling reagents and a d -alkyl amine as a nucleophile. Furthermore, liver microsomal metabolism studies revealed deuterium kinetic isotope effects (KIE) in 7-(d -ethoxy)flavone. The present concept for the synthesis of deuterated reagents and the first demonstration of a KIE in a d -ethoxy group will contribute to drug discovery research based on deuterium chemistry.
通过在杂原子的α位将更稳定的 C-D 键替代药物中的 C-H 键,可以改善药物的药代动力学性质,这是细胞色素 P450 酶的典型代谢部位。然而,氘代合成子的应用受到限制。在此,我们建立了一个新概念,用于制备氘代试剂,成功地在杂原子的α位合成了具有氘原子的复杂药物骨架。(d-烷基)二苯硫翁盐由相应的非氘代形式使用廉价且丰富的 D 2 O 作为氘源与碱反应制备,用作亲电烷基化试剂。此外,这些氘代的硫翁盐可以有效地转化为 d-烷基卤化物、d-烷基叠氮化物作为偶联试剂以及 d-烷基胺作为亲核试剂。此外,肝微粒体代谢研究揭示了 7-(d-乙氧基)黄酮中的氘动力学同位素效应(KIE)。本研究建立了氘代试剂的合成概念,并首次在 d-乙氧基中证明了 KIE,这将有助于基于氘化学的药物发现研究。